KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $367.0 million.

  • Tenet Healthcare's Free Cash Flow rose 15552.19% to $367.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.5 billion, marking a year-over-year increase of 12670.25%. This contributed to the annual value of $2.5 billion for FY2025, which is 12670.25% up from last year.
  • Per Tenet Healthcare's latest filing, its Free Cash Flow stood at $367.0 million for Q4 2025, which was up 15552.19% from $778.0 million recorded in Q3 2025.
  • Over the past 5 years, Tenet Healthcare's Free Cash Flow peaked at $829.0 million during Q3 2024, and registered a low of -$661.0 million during Q4 2024.
  • For the 5-year period, Tenet Healthcare's Free Cash Flow averaged around $325.0 million, with its median value being $336.5 million (2023).
  • Its Free Cash Flow has fluctuated over the past 5 years, first surged by 151212.12% in 2023, then tumbled by 20730.52% in 2024.
  • Quarter analysis of 5 years shows Tenet Healthcare's Free Cash Flow stood at $53.0 million in 2021, then soared by 147.17% to $131.0 million in 2022, then soared by 370.23% to $616.0 million in 2023, then crashed by 207.31% to -$661.0 million in 2024, then surged by 155.52% to $367.0 million in 2025.
  • Its Free Cash Flow was $367.0 million in Q4 2025, compared to $778.0 million in Q3 2025 and $743.0 million in Q2 2025.